Paper Details

  1. Home
  2. Paper Details

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage.

Author: JinTao, KalaycioMatt, KalmadiSujith, LoweChristopher, TiuRamon

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Epsilon aminocaproic acid (EACA) was effective in treating thrombocytopenic hemorrhage in 66% of patients, and manageable adverse effects were observed.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Epsilon aminocaproic acid (EACA) is an antifibrinolytic drug that has been used to control hemorrhage by stabilizing the thrombus. It has been used in thrombocytopenic patients largely on an empiric basis. METHODS: Concerns regarding side effects have limited the use of this drug. The a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/cncr.21958

データ提供：米国国立医学図書館（NLM）

Epsilon Aminocaproic Acid: A Potential Treatment for Thrombocytopenic Hemorrhage

Thrombocytopenic hemorrhage, characterized by low platelet counts and bleeding, can be a serious medical condition. This study explores the use of epsilon aminocaproic acid (EACA), an antifibrinolytic drug, as an adjunctive therapy for managing thrombocytopenic hemorrhage. The researchers reviewed their experience with EACA in patients with thrombocytopenic hemorrhage, analyzing its effectiveness in reducing transfusion requirements and managing side effects.

Epsilon Aminocaproic Acid: A Promising Adjunctive Therapy

The study found that EACA effectively reduced platelet and red blood cell transfusion requirements in patients with thrombocytopenic hemorrhage.

Managing Thrombocytopenic Hemorrhage: Exploring Treatment Options

This study highlights the potential of EACA as a valuable tool in the management of thrombocytopenic hemorrhage.

Dr.Camel's Conclusion

This study suggests that EACA could be a valuable addition to the treatment arsenal for patients with thrombocytopenic hemorrhage, potentially reducing the need for transfusions and improving patient outcomes.

Date :
  1. Date Completed 2006-08-16
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

16708357

DOI: Digital Object Identifier

10.1002/cncr.21958

Related Literature

Article Analysis
・Side Effects of aminocaproic acid
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.